Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
QB3
AddedFeb 13, 2024
UpdatedJun 28, 2026
QB3

QB3

San Francisco-based educational organization, California Institute for Quantitative Biosciences, advancing bioeconomy research.

HQ
Cacheu Region, GW
Founded
2000
Overview
Compare
Employees
Website

QB3, the California Institute for Quantitative Biosciences, is a collaborative research institute focused on advancing innovation in life sciences and climate technology. Based at the University of California, QB3 serves as a hub for early-stage entrepreneurship, networking, and cutting-edge research in biotechnology and climate solutions. The institute aims to address pressing challenges in health and environmental sustainability through interdisciplinary approaches.

QB3 operates several initiatives to support its mission, including the Bakar Labs incubator and the Bakar ClimatEnginuity Hub at UC Berkeley. These programs provide resources and infrastructure for startups and researchers to develop groundbreaking technologies. QB3's efforts have garnered recognition, including an East Bay Innovation Award for Bakar Labs, highlighting its significant impact on the biotech ecosystem and climate innovation landscape in California.

QB3 - Similar Companies

MBC Biolabs logo

MBC Biolabs

mbcbiolabs.com

Arcadia Science logo

Arcadia Science

arcadiascience.com

eBioinformatics logo

eBioinformatics

Q Biotech logo

Q Biotech

q-biotech.com

BioAccel logo

BioAccel

Ibbr logo

Ibbr

Benchling logo

Benchling

benchling.com

Quintarabio logo

Quintarabio

QuantumBio logo

QuantumBio

quantumbioinc.com

Triplebar logo

Triplebar

triplebar.com

Fluidigm logo

Fluidigm

standardbio.com

Correlia Biosystems logo

Correlia Biosystems

Institute for Systems Biology logo

Institute for Systems Biology

isbscience.org

Calibre Scientific logo

Calibre Scientific

Splendid Lab logo

Splendid Lab

splendidlab.com

QB3 - Quick Facts

Who are QB3's competitors?

Companies similar to QB3 include MBC Biolabs, Arcadia Science, eBioinformatics and Q Biotech.

When was QB3 founded?

QB3 was founded in 2000.

Where is QB3's headquarters located?

QB3's headquarters is located in Cacheu Region, GW.

How many employees does QB3 have?

QB3 has 31 employees as of Feb 4, 2024.

QB3 - Classification

Technology
  • Biotech
  • Cleantech
Geographic Exposure
  • United States
Customer
  • Education
  • Enterprise
  • Government
  • Non-Profit
Main Product
  • Research
Tags
  • Consulting
NAICS
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 611000Educational Services
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8200Educational Services
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 7371Computer Programming Services
  • 7372Prepackaged Software